idiopathic pulmonary fibrosis

Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital
Ilias Dimeas, Sotirios Sinis, Paraskevi Kirgou, Lampropoulos Ioannis, Foteini Malli, Konstantinos Gourgoulianis, Zoe Daniil

European Respiratory Journal Sep 2020, 56 (suppl 64) 4811; DOI: 10.1183/13993003.congress-2020.4811
Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue?
Mathieu Marillier, Anne-Catherine Bernard, Onofre Moran-Mendoza, Denis E O'Donnell, Samuel Verges, J Alberto Neder

European Respiratory Journal Sep 2020, 56 (suppl 64) 4405; DOI: 10.1183/13993003.congress-2020.4405
Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial
Gisli Jenkins, Imre Noth, Moisés Selman, Vincent Cottin, Yasuhiko Nishioka, Jin Woo Song, Antje Prasse, Eric S White, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Susanne Stowasser, Toby M Maher

European Respiratory Journal Sep 2020, 56 (suppl 64) 5187; DOI: 10.1183/13993003.congress-2020.5187
Lung ultrasound in children with interstitial lung disease: a pilot study
Celine Delestrain, Guillaume Thouvenin, Nicolas Richard, Fouad Madhi, Laura Berdah, Houmam El Jurdi, Annick Clement, Ralph Epaud, Harriet Corvol, Nadia Nathan

European Respiratory Journal Sep 2020, 56 (suppl 64) 5288; DOI: 10.1183/13993003.congress-2020.5288
Combined assessment of regional lung function and morphology using a contrast enhanced Dual-Energy CT protocol: Prospective value of functional imaging biomarkers in longitudinal analysis of patients with Interstitial Lung Disease
Sarah Scharm, Sabine Dettmer, Jens Vogel-Claussen, Antje Prasse, Lars Knudsen, Frank Wacker, Jan Fuge, Hoen-Oh Shin

European Respiratory Journal Sep 2020, 56 (suppl 64) 4575; DOI: 10.1183/13993003.congress-2020.4575
Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
Danielle Strens, Benjamin Bondue, Caroline Dahlqvist, Hans Slabbynk, Julien Guiot, Guy F. Joos, Natacha Gusbin, Wim Janssens, Antoine Froidure, Wim Wuyts

European Respiratory Journal Sep 2020, 56 (suppl 64) 4810; DOI: 10.1183/13993003.congress-2020.4810
A humanized animal model of pulmonary fibrosis based on cellular senescence
Fernanda Ines Hernandez Gonzalez, Federico Pietrocola, Neus Prats, Kathleen Meyer, Jose Alberto Lopez-Dominguez, Maria Isabel Muñoz, Miguel Rovira, Daniel Martinez, Jose Ramirez, Alvar Agusti, Rosa Faner, Jacobo Sellares, Manuel Serrano

European Respiratory Journal Sep 2020, 56 (suppl 64) 4470; DOI: 10.1183/13993003.congress-2020.4470
Biomarkers of collagen formation are predictive of IPF progression and death
Nils Hoyer, Henrik Jessen, Sarah Rønnow, Morten Karsdal, Diana Leeming, Jannie Sand, Saher Shaker

European Respiratory Journal Sep 2020, 56 (suppl 64) 5186; DOI: 10.1183/13993003.congress-2020.5186
Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial
Eric White, Vincent Cottin, Martin Kolb, Toby M Maher, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Manuel Quaresma, Bruno Crestani

European Respiratory Journal Sep 2020, 56 (suppl 64) 5189; DOI: 10.1183/13993003.congress-2020.5189
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Gali Epstein Shochet, Becky Bardenstein-Wald, Liran Dembitz, David Shitrit

European Respiratory Journal Sep 2020, 56 (suppl 64) 5031; DOI: 10.1183/13993003.congress-2020.5031

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us